Page last updated: 2024-08-24

dexmedetomidine and Carcinoma, Non-Small Cell Lung

dexmedetomidine has been researched along with Carcinoma, Non-Small Cell Lung in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Fu, C; Qiu, F; Wang, M; Zhang, K1
Gaafary, ME; Hafner, S; Huber, R; Lang, SJ; Paetz, C; Schmidt, CQ; Schmiech, M; Simmet, T; Steinborn, C; Syrovets, T; Werner, K1
Jun, JH; Kim, KS; Kwak, YL; Oh, JE; Shim, JK; Soh, S1
Ai, D; Banchs, J; Cata, JP; Feng, L; Vaporciyan, AA; Xu, G; Yu, J1
Cata, JP; Feng, L; Moon, T; Peng, SP; Tsai, JY; Vachhani, S; Vaporciyan, AA1

Other Studies

5 other study(ies) available for dexmedetomidine and Carcinoma, Non-Small Cell Lung

ArticleYear
Casticin and chrysosplenol D from Artemisia annua L. induce apoptosis by inhibiting topoisomerase IIα in human non-small-cell lung cancer cells.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 100

    Topics: Apoptosis; Artemisia annua; Carcinoma, Non-Small-Cell Lung; DNA Topoisomerases, Type II; Flavones; Flavonoids; Humans; Lung Neoplasms; Molecular Docking Simulation

2022
Antitumor activity of an Artemisia annua herbal preparation and identification of active ingredients.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 62

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Artemisia annua; Artemisinins; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Female; Flavones; Flavonoids; Humans; Leukocytes, Mononuclear; Lung Neoplasms; Mice; Mice, Nude; Plant Extracts; Xenograft Model Antitumor Assays

2019
Effects of dexmedetomidine on A549 non-small cell lung cancer growth in a clinically relevant surgical xenograft model.
    Scientific reports, 2023, 08-01, Volume: 13, Issue:1

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Dexmedetomidine; Heterografts; Humans; Inflammasomes; Inflammation; Interleukin-10; Interleukin-18; Lung Neoplasms; Mice; Mice, Nude; NLR Family, Pyrin Domain-Containing 3 Protein

2023
Dexmedetomidine does not reduce atrial fibrillation after lung cancer surgery.
    Journal of cardiothoracic and vascular anesthesia, 2015, Volume: 29, Issue:2

    Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Atrial Fibrillation; Carcinoma, Non-Small-Cell Lung; Dexmedetomidine; Female; Humans; Intraoperative Care; Lung Neoplasms; Male; Middle Aged; Postoperative Complications; Pulmonary Surgical Procedures; Retrospective Studies; Treatment Outcome

2015
The Use of Intraoperative Dexmedetomidine Is Not Associated With a Reduction in Acute Kidney Injury After Lung Cancer Surgery.
    Journal of cardiothoracic and vascular anesthesia, 2016, Volume: 30, Issue:1

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Dexmedetomidine; Female; Humans; Intraoperative Care; Lung Neoplasms; Male; Middle Aged; Pulmonary Surgical Procedures; Retrospective Studies; Risk Factors; Young Adult

2016